A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma

Melanoma Research

Volumn 18, Issue 6, 2008, Pages 400-404

  Bedikian, Agop Y ^a   Papadopoulos, Nicholas E ^a   Kim, Kevin B ^a   Vardeleon, Anna ^a   Smith, Teresa ^a   Lu, Biao ^b   Deitcher, Steven R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Hana Biosciences   (United States)

Author keywords

Choroidal; Liposome; Marqibo; Melanoma; Uveal; Vincristine

Indexed keywords

CISPLATIN; DACARBAZINE; INTERFERON; INTERLEUKIN 2; LENALIDOMIDE; LIPOSOME; PACLITAXEL; TAXANE DERIVATIVE; TEMOZOLOMIDE; THALIDOMIDE; VINBLASTINE; VINCRISTINE SULFATE;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; AGED; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; BLOOD TOXICITY; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPESTHESIA; INFECTION; INSOMNIA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; MENTAL DISEASE; METASTASIS; MUSCLE CRAMP; MYALGIA; NASOPHARYNGEAL PAIN; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RIGOR; SIDE EFFECT; SPLEEN METASTASIS; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UVEA MELANOMA; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LIPOSOMES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PILOT PROJECTS; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 56849097154     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328311aaa1     Document Type: Article

References (13)

1. Cullis PR, Kantarjian H, Appelbaum F, O'Brien S, Wong M, Choy GS, Deitcher SR. Marqibo (vincristine sulfate liposomes injection, OPTISOME) concentrates vincristine in tumor tissue and lymphoid malignancy oriented tissues in tumor-bearing mice. Blood 2007; 110 [Abstract 1403].
2. Webb MS, Harasym TO, Masin D, Bally MB, Mayer LD. Sphingomyelin cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. Br J Cancer 1995; 72:896-904.
3. Webb MS, Logan P, Kanter PM, St-Onge G, Gelmon K, Harasym T, et al. Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer. Cancer Chemother Pharmacol 1998; 42:461-470.
4. Thomas DA, Kantarjian HM, Stock W, Heffner L, Tredinnick A, Lu B, et al. Safety and efficacy of Marqibo (vincristine sulfate liposomes injection, OPTISOME) for the treatment of adults with relapsed or refractory acute lymphoblastic leukemia (ALL). Blood 2007; 110:263a [Abstract 858].
5. Bedikian AY, Vardeleon A, Smith T, Campbell S, Namdari R. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients. J Clin Pharmacol 2006; 46:727-737.
6. Hwu P, Papadopoulos N, Kim K, Vardeleon AG, Campbell S, Namdari R, et al. A pharmacokinetic comparison of the Marqibo 3 and 5 vial injection kits in metastatic melanoma patients. J Clin Oncol 2007; 25:490s [Abstract 8575].
7. Buzaid AC, Legha SS. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma. Semin Oncol 1994; 21:23-28.
8. Comis RL, Carter SK. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. Cancer Treat Rev 1974; 1:285-304.
9. Whitehead RP, Moon J, McCachren SS, Hersh EM, Samlowski WE, Beck JT, et al. A phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study. Cancer 2004; 100:1699-1704.
10. Jimeno A, Hitt R, Quintela-Fandino M, Cortés-Funes H. Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma. Anti-Cancer Drugs 2005; 16:53-57.
11. Feun LG, Savaraj N, Hurley J, Marini A, Lai S. A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma. Cancer 2000; 88:584-588.
12. Bedikian AY. Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 2006; 46:151-166.
13. Neale MH, Myatt NE, Khoury GG, Weaver P, Lamont A, Hungerford JL, et al. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res 2001; 11:601-609.